Literature DB >> 6728086

Renal handling of uric acid in patients with recurrent calcium nephrolithiasis and hyperuricosuria.

F Mateos Antón, J G Puig, G Gaspar, A Muñoz Sanz, E Herrero, T Ramos, M E Martínez, J M Gómez Mantilla.   

Abstract

Hyperuricosuria is a frequent finding in patients with recurrent calcium nephrolithiasis (RCN) that has been related to purine overingestion . The influence of diet and the renal handling of uric acid were investigated in patients with RCN to assess the pathogenic mechanism of excessive urate excretion. Among 50 patients with recurrent nephrolithiasis 42 formed renal stones containing calcium and 9 of these 42 patients demonstrated concomitant asymptomatic hyperuricosuria while on a self-selected diet. Ingestion of a purine-free diet normalized the uric acid excretion in 4 of these 9 patients. The other 5 patients showed persistent hyperuricosuria while on a purine-free diet. In order to assess a possible dysfunction in the renal handling of uric acid, pharmacological tests were undertaken in these 9 patients. Pyrazinamide administration almost completely suppressed urate excretion, excluding a presecretory reabsorption defect. Urate excretion in response to probenecid administration was decreased in 4 patients and increased in 1. This finding is in accordance with a postsecretory reabsorption defect in the former and an augmented tubular secretion of urate in the latter. This study proves that both dietary factors and tubular transport defects are involved in patients with recurrent calcium nephrolithiasis and hyperuricosuria.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6728086     DOI: 10.1159/000183227

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  1 in total

1.  Familial hypouricaemia due to an isolated tubular defect of urate reabsorption.

Authors:  D Barajas de Frutos; B Bravo Mancheño; N Palomino Urda; J Pedrero Vera
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.